3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow SRT2104: new trials by email Literature Review of SRT2104 trials Research Report on SRT2104
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type Psoriasis Placebo, SRT2104 - Psoriasis | Phase 2 | Completed | Sirtris, a GSK Company | 40 | 2010-06-07 | 2017-10-13 |
| A Clinical Study to Assess the Safety, Tolerability, and Activity of Oral SRT2104 Capsules Administered for 28 Days to Subjects With Type 2 Diabetes Mellitus Placebo, SRT2104 - Diabetes Mellitus, Type 2 | Phase 2 | Completed | GlaxoSmithKline | 86 | 2010-03-03 | 2017-04-25 |
| Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Type 2 Diabetic Human Subjects SRT2104, Placebo - Diabetes Mellitus, Type 2 | Phase 2 | Completed | Sirtris, a GSK Company | 227 | 2009-08-19 | 2018-07-13 |
Diabetes Mellitus, Type 2 (2) · Psoriasis (1)
Sirtris, a GSK Company (2) · GlaxoSmithKline (1)
Bulgaria (1) · Estonia (1) · Germany (1) · Hungary (1) · Poland (1) · Romania (1) · Russia (1) · Ukraine (1) · United Kingdom (1) · United States (1)